Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Line 244: | Line 244: | ||
<img src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100"> | <img src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100"> | ||
</div> | </div> | ||
- | <img src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width=" | + | <img src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width="200" style="position:relative;bottom:500px;left:50px;"/> |
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> |
Revision as of 08:31, 26 September 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
Our results here